BTS
BMRN icon

BB&T Securities’s BioMarin Pharmaceuticals BMRN Stock Holding History

BB&T Securities’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$230K Buy
3,460
+13
+0.4% +$1K ﹤0.01% 1445
2019
Q2 		$295K Buy
3,447
+132
+4% +$11.3K ﹤0.01% 1319
2019
Q1 		$294K Buy
3,315
+170
+5% +$15.8K ﹤0.01% 1301
2018
Q4 		$267K Buy
3,145
+245
+8% +$23.3K ﹤0.01% 1231
2018
Q3 		$281K Sell
2,900
-5,803
-67% -$579K ﹤0.01% 1341
2018
Q2 		$819K Buy
+8,703
New +$762K 0.01% 881

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return